1. Home
  2. IRMD vs ARDX Comparison

IRMD vs ARDX Comparison

Compare IRMD & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iRadimed Corporation

IRMD

iRadimed Corporation

HOLD

Current Price

$87.61

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$3.83

Market Cap

996.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRMD
ARDX
Founded
1992
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
996.8M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
IRMD
ARDX
Price
$87.61
$3.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$116.00
$15.14
AVG Volume (30 Days)
108.2K
4.8M
Earning Date
05-01-2026
04-30-2026
Dividend Yield
0.95%
N/A
EPS Growth
16.67
N/A
EPS
0.86
N/A
Revenue
$83,814,000.00
$2,607,000.00
Revenue This Year
$12.38
$37.75
Revenue Next Year
$11.31
$34.24
P/E Ratio
$101.16
N/A
Revenue Growth
14.43
N/A
52 Week Low
$67.84
$3.73
52 Week High
$107.90
$8.40

Technical Indicators

Market Signals
Indicator
IRMD
ARDX
Relative Strength Index (RSI) 41.27 27.50
Support Level $84.05 N/A
Resistance Level $88.72 $6.47
Average True Range (ATR) 2.33 0.14
MACD 0.09 0.01
Stochastic Oscillator 32.47 12.33

Price Performance

Historical Comparison
IRMD
ARDX

About IRMD iRadimed Corporation

iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: